Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

D.D. Mikol; F. Barkhof; P. Chang; P.K. Coyle; D.R. Jeffery; S.R. Schwid; B. Stubinski; B.M.J. Uitdehaag

doi:https://doi.org/10.1016/S1474-4422(08)70200-X

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

D.D. Mikol, F. Barkhof, P. Chang, P.K. Coyle, D.R. Jeffery, S.R. Schwid, B. Stubinski, B.M.J. Uitdehaag

Research output: Contribution to journal › Article › Academic › peer-review

421 Citations (Scopus)

Original language	English
Pages (from-to)	903-914
Journal	Lancet neurology
Volume	7
Issue number	10
DOIs	https://doi.org/10.1016/S1474-4422(08)70200-X
Publication status	Published - 2008

Access to Document

https://doi.org/10.1016/S1474-4422(08)70200-X

Cite this

Mikol, D. D., Barkhof, F., Chang, P., Coyle, P. K., Jeffery, D. R., Schwid, S. R., Stubinski, B., & Uitdehaag, B. M. J. (2008). Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial. Lancet neurology, 7(10), 903-914. https://doi.org/10.1016/S1474-4422(08)70200-X

@article{54dbeea1b07649bba709c5c47c69485d,

title = "Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial",

author = "D.D. Mikol and F. Barkhof and P. Chang and P.K. Coyle and D.R. Jeffery and S.R. Schwid and B. Stubinski and B.M.J. Uitdehaag",

year = "2008",

doi = "https://doi.org/10.1016/S1474-4422(08)70200-X",

language = "English",

volume = "7",

pages = "903--914",

journal = "Lancet neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "10",

}

Mikol, DD, Barkhof, F, Chang, P, Coyle, PK, Jeffery, DR, Schwid, SR, Stubinski, B & Uitdehaag, BMJ 2008, 'Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial', Lancet neurology, vol. 7, no. 10, pp. 903-914. https://doi.org/10.1016/S1474-4422(08)70200-X

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial. / Mikol, D.D.; Barkhof, F.; Chang, P. et al.
In: Lancet neurology, Vol. 7, No. 10, 2008, p. 903-914.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

AU - Mikol, D.D.

AU - Barkhof, F.

AU - Chang, P.

AU - Coyle, P.K.

AU - Jeffery, D.R.

AU - Schwid, S.R.

AU - Stubinski, B.

AU - Uitdehaag, B.M.J.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1016/S1474-4422(08)70200-X

DO - https://doi.org/10.1016/S1474-4422(08)70200-X

M3 - Article

SN - 1474-4422

VL - 7

SP - 903

EP - 914

JO - Lancet neurology

JF - Lancet neurology

IS - 10

ER -

Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR et al. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial. Lancet neurology. 2008;7(10):903-914. doi: https://doi.org/10.1016/S1474-4422(08)70200-X